Perspectives of primary care physicians on academic detailing for antimicrobial stewardship: feasibility and impact assessment

Abstract

Objective

To understand primary care physicians’ perspectives on academic detailing from an antimicrobial stewardship team to combat antibiotic overuse for upper respiratory infections and bronchitis in the COVID-19 era, which will help prevent avoidable outpatient visits.

Methods

In this prospective study, 14 female Croatian physicians completed standardized qualitative interviews using a semi-structured guide. The data were analyzed using inductive methodology based on reflexive thematic analysis. We used a theoretically informed approach based on a conceptual framework of healthcare intervention implementability focused on three domains: acceptability, fidelity, and feasibility.

Results

We identified six key themes highlighting barriers to changing prescribing practices, with patient pressure and specialist recommendations having an impact on the effectiveness of academic detailing. Despite challenges, primary care physicians described appreciation of direct interaction with evidence-based practices and reported usefulness, effectiveness, and further need for academic detailing.

Conclusion

This study highlights the complex dynamics involved in implementing healthcare interventions and provides valuable insights for enhancing strategies directed at improving antibiotic prescribing practices. Specifically, our findings emphasize factors influencing behavior changes in physicians’ antibiotic prescribing. The authors advocate for a collaborative approach involving community and hospital-based professionals to provide tailored guidance and address questions, ultimately improving prescribing practices.

Keywords

Antimicrobial resistance antimicrobial stewardship academic detailing primary care physician qualitative research healthcare intervention implementability

Introduction

Acute upper respiratory tract infections and acute bronchitis (ARI&AB) are the most common reasons for outpatient physician office visits and inappropriate antibiotic prescribing in adults, which is particularly relevant in the era of COVID-19.^1,2 Studies show that more than 90% of antibiotic prescriptions are made in the community setting, with up to 50% of those for ARI&AB being unnecessary.^1,3 This contributes to the increase in antimicrobial resistance (AMR), which has led to a 16% rise in annual European AMR deaths from 2016 to 2019.^4,5 Additionally, yearly reports from the European Centre for Disease Prevention and Control (ECDC) and World Health Organization (WHO) Regional Office for Europe indicate that resistance to antibiotics is more common in southern and eastern Europe, where antibiotic use per person is greater than that in northern Europe.⁶ For instance, the use of antibiotics in Southern European countries is approximately three times higher than that in Scandinavia and the Netherlands.⁷

Combating antibiotic-resistant bacteria is crucial, and improving antibiotic prescribing practices in healthcare settings is a key component in this effort.⁵ Antimicrobial stewardship programs (ASPs) aim to ensure the judicious use of antimicrobials and improve patient outcomes, reduce the spread of resistance, prevent deaths from resistant infections, and reduce healthcare costs.^8,9 Most ASP teams (A-teams) comprise an infectious disease physician, a clinical microbiology physician, and a clinical pharmacist.^5,10 Clinician-focused ASPs such as those involving audit feedback with peer comparison, academic detailing (AD), and clinician communication training, have been shown to be effective in reducing unnecessary antibiotic treatment of ARI&ABs.¹¹ Additionally, these programs promote evidence-based and internationally-standardized optimization of antimicrobial use.¹²

AD is an educational outreach method in which peers, colleagues, or opinion leaders including other clinicians and pharmacists, have one-on-one meetings with prescribers, providing them with the latest evidence-based information on commonly used drugs. This helps facilitate changes in antibiotic prescribing practices.¹³ AD for acute respiratory tract infections has been successful in improving antibiotic prescribing in Norway, Saudi Arabia, and the United States, leading to increased safety and savings.^14–16 For this reason, AD is one of the main antimicrobial stewardship strategies recommended in the international literature for improving prudent antibiotic use.¹⁷ Additionally, studies show that AD is suitable for keeping primary care physicians (PCPs) up-to-date and that PCPs welcome future AD visits.^18,19

Currently, there is a scarcity of research on the effectiveness of ASPs in improving prudent antimicrobial use in Southeast Europe, including during the COVID-19 pandemic.²⁰ Although clinician-focused ASPs have been successful globally, it is unknown whether AD programs would be accepted and useful in Southeast European countries such as Croatia. Furthermore, which ASP interventions are appropriate and feasible in this area remains unclear, as do the potential barriers to AD implementation.

Given the increasing concerns about unnecessary patient exposure to broad-spectrum antibiotics, trends in antimicrobial resistance patterns, and associated costs, the aim of this study was to investigate PCPs’ perspectives on usefulness, attitudes, and perceived barriers and facilitators to one-on-one education via AD intervention provided by an A-team for ARI&AB. By understanding the acceptability and effectiveness of such intervention, it will be possible to develop future strategies for safe and prudent antibiotic use, address care gaps, and promote changes in practice in Croatia as well as in other countries.

Methods

Our prospective study was part of a larger investigation on AD in Croatia. We recruited PCPs in Koprivnica-Križevci County on a voluntary basis. The AD program aimed to improve antibiotic prescribing during April 2020. The A-team, comprising infectious disease physicians, clinical microbiologists, and clinical pharmacists, conducted a regular ASP at Koprivnica-Križevci County General Hospital. With that experience, they developed educational materials tailored for primary care settings to be delivered in a 30-minute AD visit. The intervention also involved the distribution of educational materials, including posters for PCPs’ practices and patient-friendly brochures that emphasized prudent antibiotic use. The AD intervention was provided once to each PCP who agreed to participate. AD sessions consisted of a face-to-face meeting that included sharing of data on local antibiotic consumption and antimicrobial resistance data, research evidence on the consequences of imprudent antibiotic use, national and international guidelines, and examples of improved prescribing through teamwork with patients and their families.^21–23

In this study, qualitative research methods were applied, using a theoretically informed approach based on the conceptual framework of healthcare intervention implementability. This framework outlines factors that influence adoption of health interventions in routine practice, divided into five domains: acceptability, fidelity, feasibility, scalability, and sustainability.²⁴ We focused on the acceptability,²⁵ fidelity,²⁶ and feasibility²⁷ of AD intervention, which are crucial in the early phase of intervention development. Scalability and sustainability are dependent on these pre-conditions and should be re-evaluated as the intervention is implemented in diverse populations or settings.²⁴ The study adhered to the consolidated criteria for reporting qualitative research (COREQ) guidelines.^28,29

Interview guide development

The research team, comprising experts in clinical pharmacy (DKP), infectology (VM), clinical microbiology (VJP), primary care (APA), university research clinical pharmacy (DKP), and a health services researcher (MK), developed a semi-structured interview guide (see Additional file 2). The guide was designed based on three domains of the healthcare intervention implementability framework: acceptability, fidelity, and feasibility. The questions explored PCPs’ views on the usefulness of AD, their attitudes toward AD, and their perceived effectiveness of AD intervention as an ASP. The investigated aspects of the domain fidelity included adherence to guidelines after AD intervention, likelihood of recommending the intervention to other PCPs, and potential for intervention repetition. Feasibility concerns were addressed, such as operational issues for AD implementation in everyday practice and any impact on PCPs’ practices. The interview started with open-ended questions, with subsequent follow-up prompts. A pilot test was conducted among three PCPs, two of whom were not part of the study, to ensure comprehension, clarity, and content validity of the questionnaire.

Ethical approval statement and consent to participate

This study was reviewed and approved by The Regional Ethical Committee for Medical and Health Research Ethics for Outpatient Clinics of Koprivnica-Križevci County (reference number 2137-16-5266/2021; 28 September 2021). All methods were carried out in accordance with Declaration of Helsinki and national relevant guidelines and regulations. Written and/or verbal informed consent was obtained from all participants depending upon whether the interview was conducted in person (written and verbal) or by telephone (verbal).

Recruitment and data collection

Selective recruitment for the study occurred between 1 September and 30 November 2022. All 16 PCPs from Koprivnica-Križevci County, Croatia who participated in a previous AD study were contacted. Qualitative interviews were conducted one-on-one by telephone or at each PCP’s clinic by a researcher (DKP) with qualitative research and AD experience. The study overview and sample questions were explained; with verbal consent, interviews were audio recorded and transcribed anonymously. The sample size was determined upon reaching theoretical saturation, meaning that no new information was obtained from additional interviews. Transcripts were offered for review, but all participants declined owing to time constraints. Data were securely stored at the General Hospital “Dr. Tomislav Bardek” Koprivnica. No compensation was provided to participants.

Data analysis

Two researchers (MK and DKP) conducted the analysis using an inductive approach based on reflexive thematic analysis, as proposed by Braun and Clarke.³⁰ The six-phase analysis framework was followed. The researchers familiarized themselves with the data by reading and highlighting key points. Codes were generated collaboratively, labeling data extracts and identifying patterns. Discussions and re-readings were carried out to refine the codes until all relevant data items were included. The themes were defined and a report was written. Owing to a manageable data volume, Microsoft Word was used for the analysis. The results were then mapped to the domains of acceptability, fidelity, and feasibility in the conceptual framework of implementability of healthcare interventions. PCPs’ details were de-identified such that participants could not be identified in any way.

Results

Of the 16 PCPs contacted, 14 completed the interview and were included in the analysis. Demographics, employment status, and location of PCPs’ practice are presented in Table 1. Regarding the reasons for declining to participate in the interview, one PCP expressed a lack of interest and the other was on long-term sick leave. Only female physicians agreed to participate in the study. Participants had practiced for an average 27.9 (standard deviation 11.9) years. Ten PCPs refused audio recording, so notes were taken. Interviews ranged from 20 to 40 minutes, averaging 30 minutes in length. Six themes were identified within the domains of acceptability, fidelity, and feasibility. Information and representative quotes for each theme are presented in Table 2.

Table 1.

PCPs’ demographic information, employment status, and location of practice

	n (%)
Sex
Female	14 (100)
Race and ethnicity
White	14 (100)
Age range, years
25–34	2 (14.3)
35–44	3 (21.4)
45–54	2 (14.3)
55–64	5 (35.7)
65–75	2 (14.3)
Employment status
Full-time	14 (100)
Location of practice
Urban	10 (71.4)
Suburban	2 (14.3)
Rural	2 (14.3)
Years in practice	n (standard deviation)
Mean	27.9 (11.9)

PCP, primary care physician.

Table 2.

Identified themes and relationships within the conceptual model.

Concept	Theme	Explanation	Sample quotes
AcceptabilityBased on the theoretical framework of acceptability²⁵	Usefulness of AD as an ASP	PCPs gain knowledge and experience regarding facts about AMR in the local environment, the most recent evidence, and guidelines on prudent use of antibiotics	Before academic detailing, I knew about AMR, but I was not aware that AMR was so widespread in our county and that made me even more careful about what I am prescribing (PCP #2).Having an insight into the newest guidelines, which were explained and made more understandable for me; facts on the nature of antibiotic prescribing in the local community in primary and secondary care and the impact of prescribing on AMR were most influential to my prescribing practices (PCP #9). Yes, it was very comprehensive and I support such [AD] interventions that help me in my everyday practice (PCP #10).I have more self-confidence in not prescribing when not having an indication for antibiotics (PCP #13).Factors that have made me stringent in antibiotic prescribing after AD include data on local antibiotic resistance patterns, recommendations from a microbiology specialist (such as in the case of a chronic wound swab that does not require antibiotics), and current developments in the field of antibiotic treatment (PCP #15).
	2. Antibiotic prescribing over time and perceived effectiveness of AD	Despite not reporting clear goals, PCPs are stricter and more self-confident when deciding to prescribe antibiotics	Not a clear plan, but [after AD], I am trying more rigorously to decide based on the clinical status of patients, and if needed, ordering further laboratory tests. They can help me guide a decision on antibiotic prescribing. If laboratory tests show that the patient did not react to an antibiotic or the inflammatory markers are inside the reference range, I stop the antibiotic. But I prescribe antibiotics very rationally, so this does not happen often (PCP #2).After undergoing academic detailing, I do not have a clear plan, but I am more cautious and take into consideration local antibiotic resistance patterns when making decisions on antibiotic prescriptions (PCP #3).Only one prescriber reported not changing her behavior for the following reason: My goals and attitudes did not change as I have a plan from before. AD intervention just confirmed my attitude (PCP #5).
Fidelity Based on the framework from the National Institute of Health Behaviour Change Consortium²⁶	3. AD as an intervention for further reinforcement of prudent antibiotic use	Better adherence to guidelines after AD. Need for education on a regular basis for PCPs as well as for other health care professionals and in other settings (e.g., preschool education)AD or similar education is likely to be recommended to colleagues in PCPs’ practice	Live lectures every 6 or 12 months in small groups, more like a workshop, to remind me to continue being adherent to guidelines, which were nicely presented at [AD] intervention (PCP #1).[AD] intervention improved my adherence to the guidelines and this or something similar should be repeated. Education of young physicians in the community and hospitals, lectures from an A-team every 6 months, brochures, education of patients. A problem is the Internet, which has a lot of non-evidence-based information and which patients follow much easier than our evidence-based recommendations. Education of younger primary care physicians and others in primary care in intermediate shifts when we are all here, for example between 1 and 2 pm (PCP #3).Paper leaflets for patients on why he/she does not have to take antibiotics and what to do for self-care of viral infection, live lectures on this topic one or two times per year, education of physicians from other specialties such as the emergency department (PCP #13).Yes (I would recommend AD intervention to other PCPs). I would suggest you come to our intermediate shift, so you can reach more fellow physicians (PCP #5).I think that [other PCPs] would be keen on getting to know current news regarding prudent use of antibiotics by having [AD] intervention or something similar (PCP #10).
	4. Influence of pharmaceutical promotion on antibiotic prescribing practices after AD intervention	AD intervention helped PCPs in maintaining implementation of guidelines and latest evidence	[Pharmaceutical representatives] do not motivate us to prescribe antibiotics. They just come with information on shortages and availability of antibiotics. [Pharmaceutical representatives] even come and bring national guidelines for antibiotic prescribing that we discussed during AD intervention (PCP #3). No, pharmaceutical representatives do not encourage me or my colleagues to prescribe more antibiotics. I also refreshed my knowledge through AD intervention, which made me more self-confident; therefore, it would be more difficult for them if trying to persuade me to prescribe what they want. Actually, they do not come so often for information on antibiotics as is the case for other classes of medicines (PCP #10).Only one PCP reported an influence:Yes, pharmaceutical representatives try to influence my prescribing practices for antibiotics, although I do not follow their recommendation if not necessary. An example is when changing the prescribed antibiotic to one from another manufacturer owing to unavailability of the prescribed antibiotic (PCP #9).
Feasibility Based on definition for implementation: the extent to which the intervention can be delivered as planned²⁷	5. Working environment barriers for implementing AD	Working environment affects PCPs' prescribing practices and sometimes represents a barrier to implementing AD intervention, especially patient pressure, recommendations from other health care specialists, or a combination of both	The biggest barriers in being rational after AD intervention are pressure from patients and recommendations from hospital specialists. Especially, if I do not have time, I almost always prescribe what has been recommended at a hospital clinic despite not being a rational decision as the pressure from the patient in that situation is very difficult to handle (PCP #1).My prescribing practices are affected by the AD intervention but also by recommendations from secondary care physicians such as surgeons, pressure from patients, and particularly if the weekend is coming and I am not able to see if a patient’s clinical picture will develop into bacterial infection or not…sometimes I do not prescribe antibiotics as it is not recommended in the guidelines or evidence that was presented during AD intervention, and this is a good service. But sometimes I give in under pressure and prescribe antibiotics despite knowing that this is not rational; it is difficult to be in this kind of situation (PCP #4).I liked that the AD intervention was practical, despite not being very keen about it at first. This secondary care combination together with colleagues, who are very communicative and cooperative from my work environment in primary care, helps me; so when in doubt, we discuss with each other. However, owing to pressure from patients, I almost always prescribe antibiotics when recommended by a secondary care physician, despite not being a rationale decision. Sometimes, I order additional lab or x-ray exams, which help me in discontinuing the antibiotic (PCP #6).Lack of time:Lack of time because of too many patients is for me the biggest barrier to rational prescribing after AD intervention (PCP #11).The biggest barriers to prudent antibiotic use [after AD intervention] are pressure from patients, recommendations from secondary care, and lack of time (PCP #14).Shortages of antibiotics:I think I have just one big barrier, which is pressure from patients. But in the current situation, we also have shortages of antibiotics, such as co-amoxiclav so we have to prescribe another generation of antibiotics; but this is an extraordinary situation. It is not my everyday practice. Also, I would like to add a lack of point of care tests in everyday practice, which would make AD intervention even more successful (PCP #2).Yes, depends on the situation. If I have time, I do not prescribe any antibiotics, but at other times I prescribe a lot of antibiotics owing to recommendations from the emergency department such as for various bacterial febrile conditions or infected wounds, despite knowing that it is not according to the guidelines or evidence mentioned in the AD intervention. A big problem is young physicians, such as young physicians from other specialties like surgeons and emergency department physicians, who prescribe co-amoxiclav for almost everything. Now, when we have a shortage of this antibiotic, they prescribe clindamycin for everything. They have also started to prescribe ciprofloxacin, but we here in primary care manage to control it with the help of the A-team from the hospital. They prescribe ciprofloxacin together with doxycycline for urinary tract infection or COVID-19 infection. Ciprofloxacin in these situations is not according to the guidelines and we have a lot of difficulties with patients if we don’t prescribe something that the physician from a hospital emergency department has recommended. The problem is even bigger if they have—according to the discharge letter from the emergency department in primary or secondary care or a secondary care specialist—already borrowed from a community pharmacy, so [primary care physicians] have to prescribe it (PCP #3). [The biggest barriers to implementation of AD intervention are] pressure from patients, lack of time, and shortages of co-amoxiclav (PCP#10).
	6. Impact of AD intervention on PCPs’ concerns regarding practices	Not being concerned about the impact of AD on PCP’s practice if not prescribing antibiotics	I am quite strict in antibiotic prescribing and patients are aware of that so I do not come into conflict with them. I give in very, very rarely. I am not concerned about the impact on my practice even if I became stricter in prescribing after the AD intervention. My patients are quite used to it and they can go seek antibiotics from other PCPs if they want (PCP #2).I am not worried about the impact on my practice. The [patients] are aware of my responsible prescribing habits and AD intervention confirmed my approach in maintaining my rigorous prescribing practices. I am also aware that my patients go to other PCPs seeking antibiotics if I do not prescribe them. They always come back to me with other issues not related to antibiotics as they know my attitude. But I am not concerned about it at all (PCP #16).Only one PCP reported concern, depending on the situation: Depends on the situation, sometimes yes and sometimes I am not [concerned on the impact on my practice]. What really concerns me is that, despite a lot of effort and time dedicated to explaining, patients still do not have an understanding of why they did not get antibiotics and go elsewhere seeking an antibiotic. This kind of [AD intervention] education should be also designed for patients to better understand the importance of prudent antibiotic use and their active involvement in this (PCP #12).
Scalability	PCP’s views on scalability of AD	This concept is encompassed within Theme 3 (AD as an intervention for further reinforcement of prudent antibiotic use) and Theme 5 (working environment barriers for implementing AD)
Sustainability	PCPs’ views of sustainability of AD	This concept is encompassed within Theme 3 (AD as an intervention for further reinforcement of prudent antibiotic use)

Note: The table is based on an example plan for using the framework of implementability of Klaic M. et al., 2022.

AD, academic detailing; AMR, antimicrobial resistance; ASP, antimicrobial stewardship program; PCP, primary care physician.

Acceptability

Theme 1: Usefulness of AD as an ASP

The interview started with questions about PCPs’ antibiotic prescribing practices and changes since graduation from medical school. Most PCPs reported making changes with experience, but three said they had strictly maintained the same practices since graduation. One PCP was in the process of gaining further experience, and another did not specify a reason.

All PCPs agreed that the AD intervention was appropriate and useful for improving their practice. They discussed how participating in AD provided them with knowledge about the widespread issue of AMR in their community, which changed their attitude toward prescribing practices. They noted that this information was not available from other resources they had used previously. PCPs valued the clear explanation in the guidelines for practically treating ARI&AB, which was specific to their local practices. They also appreciated the focus on raising awareness about prudent antibiotic use as part of the AD intervention.

Before academic detailing, I knew about AMR, but I was not aware that AMR was so widespread in our county and that made me even more careful about what I am prescribing (PCP #2).

Factors that have made me stringent in antibiotic prescribing after AD include data on local antibiotic resistance patterns, recommendations from a microbiology specialist—such as in the case of a chronic wound swab that does not require antibiotics—and current developments in the field of antibiotic treatment (PCP #15).

Theme 2: Antibiotic prescribing over time and perceived effectiveness of AD

PCPs embraced the challenge of setting clear goals, aiming to be more stringent in their antibiotic prescribing decisions. Over time after AD, most PCPs reported effective rational prescribing owing to increased knowledge, an improved decision-making process, and greater self-confidence in not prescribing antibiotics.

Not a clear plan, but [after AD] I am trying more rigorously to decide based on the clinical status of patients, and if needed, ordering further laboratory tests. They can help me guide a decision on antibiotic prescribing. If laboratory tests show that the patient did not react to an antibiotic or the inflammatory markers are inside the reference range, I stop the antibiotic. But I prescribe antibiotics very rationally, so this does not happen often (PCP #2).

After undergoing academic detailing, I do not have a clear plan, but I am more cautious and take into consideration local antibiotic resistance patterns when making decisions on antibiotic prescriptions (PCP #3).

One PCP noted that AD intervention only confirmed her knowledge and current practices.

Fidelity

Theme 3: AD as an intervention for further reinforcement of prudent antibiotic use

PCPs improved their adherence to guidelines after AD intervention and stressed the importance of one or two lectures per year on maintaining restrictive antibiotic prescribing. They also highlighted the need for education among primary and secondary care colleagues, undergraduate students, preschoolers, school children, and patients. Written materials were suggested for further support.

Live lectures every 6 or 12 months in small groups, more like a workshop, to remind me to continue being adherent to guidelines, which were nicely presented at [AD] intervention (PCP #1).

Most PCPs agreed to recommend another AD intervention for colleagues from their practice, but two were unsure.

I think that [other PCPs] would be keen on getting to know current news regarding prudent use of antibiotics by having [AD] intervention or something similar (PCP #10).

Theme 4: Influence of pharmaceutical promotion on antibiotic prescribing practices after AD intervention

Most PCPs reported no influence from the pharmaceutical industry regarding antibiotic prescribing. AD intervention helped them stay up to date with the guidelines and ensure optimal patient care.

No, pharmaceutical representatives do not encourage me or my colleagues to prescribe more antibiotics. I also refreshed my knowledge through AD intervention, which made me more self-confident; therefore, it would be more difficult for them if trying to persuade me to prescribe what they want. Actually, they do not come so often for information on antibiotics, as is the case for other classes of medicines (PCP #10).

Only one PCP reported an influence:

Yes, pharmaceutical representatives try to influence my prescribing practices for antibiotics, although I do not follow their recommendation if not necessary. An example is when changing the prescribed antibiotic to one from another manufacturer owing to unavailability of the prescribed antibiotic (PCP #9).

Feasibility

Theme 5: Working environment barriers to implementing AD

Despite its practicality and high acceptance, PCPs acknowledged that the work environment can influence their prescribing practices. PCPs reported that they sometimes yield to patient pressure or recommendations from other healthcare specialists or a combination of both. After the AD intervention, PCPs also identified lack of time as a barrier to adhering to prudent antibiotic prescribing. As for challenges, three PCPs mentioned a shortages of antibiotics, and one mentioned a lack of point-of-care tests.

I think I have just one big barrier, which is pressure from patients. But in the current situation, we also have shortages of antibiotics, such as co-amoxiclav, so we have to prescribe another generation of antibiotics; but this is an extraordinary situation. It is not my everyday practice. Also, I would like to add a lack of point of care tests in everyday practice, which would make AD intervention even more successful (PCP#2).

Theme 6: Impact of AD intervention on concerns regarding PCP practices

Almost all PCPs expressed confidence that the AD intervention reinforced their responsible prescribing habits.

I am not worried about an impact on my practice. [Patients] are aware of my responsible prescribing habits and AD intervention confirmed my approach in maintaining my rigorous prescribing practices. I am also aware that my patients go to other PCPs seeking antibiotics if I do not prescribe them. They always come back to me with other issues not related to antibiotics as they know my attitude. But I am not concerned about it at all (PCP #16).

Only one PCP reported an occasional concern:

Depends on the situation, sometimes yes and sometimes I am not [concerned about the impact on my practice]. What really concerns me is that, despite a lot of effort and time dedicated to explaining, patients still do not have an understanding of why they did not get antibiotics and go elsewhere seeking an antibiotic. This kind of [AD intervention] education should also be designed for patients to better understand the importance of prudent antibiotic use and their active involvement in this (PCP #12).

PCPs’ views on the scalability and sustainability of AD in the Croatian healthcare system were not explored in depth and are encompassed within the domains of fidelity (themes 3 and 5) and feasibility for scalability (theme 5).

Discussion

Our study aimed to explore the views of PCPs regarding implementation of AD as an ASP in Croatia with respect to usefulness, attitudes, and perceived barriers and facilitators to changing prescribing practices, including during the COVID-19 era. We found that pressure from patients and recommendations from hospital specialists were the main barriers to AD implementation. Despite challenges, PCPs appreciated the direct interaction and evidence-based practices promoted in AD, suggesting its potential to reduce inappropriate antibiotic use and combat AMR. This study underscores the importance of personalized interaction with experts to address knowledge gaps and promote responsible antibiotic use. However, our study was focused on PCPs’ opinions and attitudes and lacked objective outcomes. Further research is needed to assess the effectiveness of AD in reducing inappropriate antibiotic prescribing and improving patient outcomes.

The impact of COVID-19 on the diagnosis and treatment of ARI&AB is a crucial consideration in the context of this study. It also underscores the need for ongoing research and investigation into the intersection of infectious diseases and AMR. The COVID-19 pandemic has substantially altered the diagnostic process for these diseases owing to the overlap of symptoms with COVID-19, potentially impacting the accuracy of diagnoses and treatment decisions.^31–33 This may lead to challenges in distinguishing between COVID-19 and other respiratory illnesses as well as the possibility of misdiagnosis or delayed diagnosis.³⁴ The weighted-incidence syndromic combination antibiogram could be used as a tool to combat these difficulties, including AMR. Because this approach considers the body site from which the organism is recovered, it gives a weighted susceptibility to all organisms causing a specific infection-related syndrome.³⁵ This may comprise a part of AD, if available, with an A-team ensuring the dissemination of syndromic antibiogram results among healthcare professionals. As such, it is essential for healthcare professionals to remain informed about the latest diagnostic protocols and guidelines and to collaborate with infectious disease experts (such as an A-team) to ensure the most accurate diagnoses and treatments. Furthermore, this study highlights the importance of developing and implementing adaptive strategies for addressing the growing threat of AMR, considering the constantly evolving landscape of infectious diseases. For instance, evidence-based behavior change techniques that emphasize the importance of health consequences have been shown to be effective in improving prescribing practices, especially when targeting individual physicians rather than larger groups or institutions.^36,37 We recommend repeating and evaluating these techniques at least once or twice per year, as suggested by the PCPs in our study, to assess the sustainability of AD. Furthermore, regular AD interventions can also increase PCPs’ self-confidence in resisting patients’ demands, which was identified as a leading driver of inappropriate prescribing in our study as well as in other studies.^36,38 Future research should examine how our AD intervention can be scaled up, as it is shown to increase PCPs’ confidence in using their clinical judgment for prudent antibiotic prescribing.

Additionally, it may be important to consider the potential impact of COVID-19 on patients’ demands for antibiotics because patients may be more likely to request antibiotics out of fears related to COVID-19. Consequently, it may be beneficial to include evidence-based behavior change techniques that address patient demands in addition to those emphasizing the importance of antibiotics’ health consequences. The approach to tackle AMR is relevant but the impact of COVID-19 on the diagnostic process and patients’ behavior toward antibiotics should also be considered.

Among others, fear of complications and insufficient knowledge about ARI&AB are important factors that contribute to inappropriate antibiotic prescribing.^36,39 In our research, we found that PCPs do not fear complications of ARI&AB but rather that hospital physicians recommend antibiotics owing to fear of these complications. To overcome this challenge, improving education and knowledge could have a large impact on reducing unnecessary antibiotic prescribing. PCPs should be provided with facts regarding the rarity of ARI&AB complications compared with the frequency of antibiotic-associated adverse drug events. For instance, the number needed to treat to prevent one serious complication is more than 4000, whereas 19.3% of all emergency department visits are related to drug-related adverse events.^40–42 This information can have an important impact on reducing unnecessary antibiotic prescribing. In addition to improving education and knowledge, regular AD intervention can also help reduce the number of recommendations for antibiotics from hospital healthcare specialists and increase PCPs’ confidence in using their clinical judgment for prudent antibiotic prescribing. Supporting approaches that target changing these factors can help overcome the challenge of inappropriate antibiotic prescribing for fear of complications and insufficient knowledge about ARI&AB.

In addition to the factors mentioned above, our study also aimed to explore other potential drivers of inappropriate antibiotic prescribing. Interestingly, we found that PCPs are not concerned about losing patients or receiving encouragement from the pharmaceutical industry. This is a crucial finding because these factors are often mentioned as potential drivers of inappropriate antibiotic prescribing. The lack of concern about losing patients may indicate that PCPs prioritize the health and well-being of their patients above all else. This finding is reassuring as it suggests that PCPs are not motivated by financial gain or personal interest when making decisions about antibiotic prescribing. Similarly, the lack of concern about receiving encouragement from the pharmaceutical industry suggests that PCPs are not influenced by external pressures or incentives to prescribe antibiotics. This finding is of interest because the pharmaceutical industry has been known to engage in marketing practices that promote the use of antibiotics, even when they are not medically necessary. These findings have important implications for efforts to reduce inappropriate antibiotic prescribing, suggesting that interventions targeting changes in PCPs’ attitudes and behaviors may be more effective than interventions focused solely on external factors, such as financial incentives or marketing practices.

Antibiotic shortages is an issue that has been increasingly reported by healthcare providers in recent years.^43,44 Although only a few participants in our study reported this as a problem, it is important to acknowledge the potential impact of shortages on irrational antibiotic prescribing. Because antibiotics are the medication most affected by shortages, substitution remains a leading strategy to mitigate this issue. However, this strategy carries several risks, including the potential for AMR and suboptimal health outcomes.⁴⁴ To address this issue, it is important to provide education and training to healthcare providers, such as via AD intervention, to ensure that appropriate prescribing practices are followed even in the context of shortages. This could include strategies to optimize the use of antibiotics, such as limiting their use to patients who truly need them and using narrow-spectrum antibiotics whenever possible. Additionally, it may be necessary to explore alternative strategies to manage infections in the context of shortages, such as using non-antibiotic therapies or infection prevention and control measures to reduce the spread of infection. Addressing the issue of antibiotic shortages and ensuring that healthcare providers have the tools and knowledge necessary to make informed decisions about antibiotic prescribing can help mitigate the potential harms associated with antibiotic shortages and ensure that patients receive the appropriate care they need.

Future research should focus on designing educational programs using AD as a strategy for mitigating AMR, which can assist policymakers in creating an environment that fosters prudent antibiotic use. AD can provide personalized interaction with experts in the field, which can help address any uncertainties related to the diagnosis and treatment of ARI&AB, especially within the context of the COVID-19 era. This approach can also improve communication and information exchange between hospital and community settings, which is crucial to ensuring that patients receive appropriate care.^45,46 Future research should also evaluate the effectiveness and sustainability of AD interventions in different settings and populations and explore ways to scale up these interventions to reach more healthcare providers. Additionally, researchers should investigate the impact of AD on patient outcomes, such as antibiotic resistance and adverse drug events, to determine the full extent of its benefits. Overall, AD has the potential to be a valuable tool in the fight against AMR and should be further explored and utilized in educational programs aimed at improving antibiotic prescribing practices.

Despite its contributions, our study has several limitations that should be considered. One of the main limitations is the small number of PCPs who participated in the AD intervention owing to the low response rate and their availability. PCPs have a heavy workload, making it difficult for them to participate in non-essential activities such as research. Moreover, the PCPs who participated in this study may be more open to new experiences and more willing to share their views on prescribing practices than those who did not participate. Because this was a qualitative study, we were unable to measure the effectiveness of AD intervention in terms of real outcomes. To elucidate how to improve antibiotic prescribing practices, a quantitative study has also been performed, which is registered on ClinicalTrials.gov with the identifier NCT05090475. Furthermore, the geographic specificity of our study, which was conducted among PCPs in Croatia, may also limit the generalizability of our results to other healthcare settings or countries. However, using a qualitative approach allowed us to gain a deeper understanding of the subjective experiences and perspectives of PCPs, which can provide valuable information for the development of future ASPs that are effective and acceptable in various healthcare settings.

Conclusion

Our study investigated the opinions of PCPs after AD and their behavioral changes in decision-making regarding antimicrobial drug prescription, specifically in the context of ARI&AB, which is particularly relevant in the challenging era of COVID-19. Our findings demonstrate the potential of AD as part of a broader strategy for antimicrobial stewardship in improving the quality of broad-spectrum antibiotic prescribing in primary care. By promoting evidence-based practices through direct interactive education, AD may be an effective intervention to reduce the negative consequences of inappropriate antibiotic use on public health and slow the spread of AMR. However, further research is needed to determine the effectiveness of AD in reducing inappropriate antibiotic prescribing and improving patient outcomes. Furthermore, continuing education for both PCPs and other healthcare professionals is critical to transform the culture of irrational antibiotic prescribing. The insights gained from our study may inform the development of future ASPs and help policymakers create targeted initiatives to enhance clinical decision-making, focusing on AD implementation and collaboration between primary and secondary healthcare. Although education itself may not be a standalone solution, it remains a valuable tool in broader efforts to address the complex challenges posed by AMR.

Supplemental Material

sj-pdf-1-imr-10.1177_03000605231222242 - Supplemental material for Perspectives of primary care physicians on academic detailing for antimicrobial stewardship: feasibility and impact assessment

Supplemental material, sj-pdf-1-imr-10.1177_03000605231222242 for Perspectives of primary care physicians on academic detailing for antimicrobial stewardship: feasibility and impact assessment by Darija Kuruc Poje, Maja Kuharić, Ana Posavec Andrić, Vesna Mađarić, Janeš Vlatka Poje, Marina Payerl-Pal, Arjana Tambić Andrašević, Juraj Mark Poje, Vesna Bačić Vrca and Srećko Marušić in Journal of International Medical Research

Supplemental Material

sj-pdf-2-imr-10.1177_03000605231222242 - Supplemental material for Perspectives of primary care physicians on academic detailing for antimicrobial stewardship: feasibility and impact assessment

Supplemental material, sj-pdf-2-imr-10.1177_03000605231222242 for Perspectives of primary care physicians on academic detailing for antimicrobial stewardship: feasibility and impact assessment by Darija Kuruc Poje, Maja Kuharić, Ana Posavec Andrić, Vesna Mađarić, Janeš Vlatka Poje, Marina Payerl-Pal, Arjana Tambić Andrašević, Juraj Mark Poje, Vesna Bačić Vrca and Srećko Marušić in Journal of International Medical Research

Footnotes

Acknowledgements

We would like to extend our sincere thanks to everyone who participated in the project: primary care physicians, administrative assistants, IT assistants, and principals from all relevant health care institutions. Special thanks to supporters of the project, namely, Darko Koren and Ratimir Ljubić from Koprivnica-Križevci County and Mato Devčić from General Hospital “Dr. Tomislav Bardek” Koprivnica, Croatia.

Author contributions

The study design was developed by DKP, MK, APA, VM, and VJP. Data collection was done by DKP. Data analysis and writing were conducted by DKP and MK. Reviewing an editing was carried out by MPP, ATA, JMP, VBV, and SM. All authors read and approved the final manuscript.

Data availability statement

The datasets used and analyzed in this study are not publicly available but are available from the corresponding author upon reasonable request.

Declaration of conflicting interests

The authors declare that there is no conflict of interest.

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

ORCID iD

Darija Kuruc Poje

References

Fleming-Dutra

Hersh

Shapiro

, et al. Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011. JAMA 2016; 315: 1864–1873.

National Institute for Health and Care Excellence (NICE). Cough (acute): antimicrobial prescribing. NICE guideline [NG120]. London: Public Health England, 2019; 978-1-4731-3263-4.

European Centre for Disease Prevention and Control. Antimicrobial consumption in the EU/EEA (ESAC-Net) -Annual Epidemiological Report 2021. Stockholm: ECDC, 2022.

European Centre for Disease Prevention and Control. Assessing the health burden of infections with antibiotic-resistant bacteria in the EU/EEA, 2016–2020. Stockholm: ECDC, 2022.

European Commission. A European One Health Action Plan against Antimicrobial Resistance. 2017. https://health.ec.europa.eu/antimicrobial-resistance/eu-action-antimicrobial-resistance_en.

European Centre for Disease Prevention and Control and WHO Regional Office for Europe. Surveillance of antimicrobial resistance in Europe, 2021 data. Executive Summary. Stockholm: ECDC, 2022.

Bruyndonckx

Adriaenssens

Versporten

, et al.; the ESAC-Net study group. Consumption of antibiotics in the community, European Union/European Economic Area, 1997-2017. J Antimicrob Chemother 2021; 76: ii7–ii13.

Nathwani

Varghese

Stephens

, et al. Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review. Antimicrob Resist Infect Control 2019; 8: 35.

Kuruc Poje

Mađarić

Janeš Poje

, et al. Antimicrobial stewardship effectiveness on rationalizing the use of last line of antibiotics in a short period with limited human resources: a single centre cohort study. BMC Res Notes 2019; 12: 531.

10.

De With

Allerberger

Amann

, et al. Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases. Infection 2016; 44: 395–439.

11.

Drekonja

Filice

Greer

, et al. Antimicrobial stewardship in outpatient settings: a systematic review. Infect Control Hosp Epidemiol 2015; 36: 142–152.

12.

Dyar

Beović

Pulcini

, et al.; ESCMID generic competencies working group. ESCMID generic competencies in antimicrobial prescribing and stewardship: towards a European consensus. Clin Microbiol Infect 2019; 25: 13–19.

13.

Soumerai

Avorn

Principles of educational outreach (‘academic detailing’) to improve clinical decision making. JAMA 1990; 263: 549–556.

14.

Gjelstad

Høye

Straand

, et al. Improving antibiotic prescribing in acute respiratory tract infections: cluster randomised trial from Norwegian general practice (prescription peer academic detailing (Rx-PAD) study). BMJ 2013; 347: f4403.

15.

Al-Tawfiq

Alawami

AH.

A multifaceted approach to decrease inappropriate antibiotic use in a pediatric outpatient clinic. Ann Thorac Med 2017; 12: 51–54.

16.

Solomon

Van Houten

Glynn

, et al. Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med 2001; 161: 1897–1902.

17.

Ndefo

Norman

Henry

Academic Detailing Has a Positive Effect on Prescribing and Decreasing Prescription Drug Costs: A Health Plan’s Perspective. Am Health Drug Benefits 2017; 10: 129–133.

18.

Dyrkorn

Langaas

Giverhaug

, et al. Academic detailing as a method of continuing medical education. Adv Med Educ Pract 2019; 10: 717–725. doi: 10.2147/AMEP.S206073.

19.

Allen

Ferrier

O’Connor

, et al. Family physicians’ perceptions of academic detailing: a quantitative and qualitative study. BMC Med Educ 2007; 7: 36.

20.

European Centre for Disease Prevention and Control (ECDC). Antimicrobial stewardship. Directory: Guidance on prevention and control. [Online] ECDC, 2022, 10 6 2022. [Cited: 17 12 2022.] https://www.ecdc.europa.eu/en/publications-data/directory-guidance-prevention-and-control/prudent-use-antibiotics/antimicrobial.

21.

Harris

Hicks

Qaseem

; High Value Care Task Force of the American College of Physicians and for the Centers for Disease Control and Prevention. Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med 2016; 164: 425–434.

22.

Interdisciplinarna sekcija za kontrolu rezistencije na antibiotike (ISKRA). ISKRA smjernice. [Mrežno] ISKRA, 2020. [Cited: 21. 01 2023.] https://iskra.bfm.hr/iskra-smjernice/.

23.

National Institute for Health and Care Excellence (NICE). NICE Guidance. Respiratory infections. NICE. [Mrežno] 2020. [Citirano: 21. 01 2023.] https://www.nice.org.uk/guidance/conditions-and-diseases/respiratory-conditions/respiratory-infections/products?GuidanceProgramme=guidelines.

24.

Klaic

Kapp

Hudson

, et al. Implementability of healthcare interventions: an overview of reviews and development of a conceptual framework. Implement Sci 2022; 17: 10.

25.

Sekhon

Cartwright

Francis

JJ.

Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res 2017; 17: 88.

26.

Bellg

Borrelli

Resnick

, et al.; Treatment Fidelity Workgroup of the NIH Behavior Change Consortium. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium. Health Psychol 2004; 23: 443–451.

27.

Bowen

Kreuter

Spring

, et al. How we design feasibility studies. Am J Prev Med 2009; 36: 452–457.

28.

Tong

Sainsbury

Craig

Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 2007; 19: 349–357. doi: 10.1093/intqhc/mzm042.

29.

Von Elm

Altman

Egger

, et al.; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 2007; 147: 573–577.

30.

Braun

Clarke

Using thematic analysis in psychology. Qualitative Research in Psychology 2006; 3: 77–101.

31.

Agca

Akalin

Saglik

, et al. Changing epidemiology of influenza and other respiratory viruses in the first year of COVID-19 pandemic. J Infect Public Health 2021; 14: 1186–1190.

32.

Rodríguez-Baño

Rossolini

Schultsz

, et al. Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance. Trans R Soc Trop Med Hyg 2021; 115: 1122–1129.

33.

Chow

Uyeki

Chu

HY.

The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol 2023; 21: 195–210.

34.

Coleman

Manavi

Marson

, et al. COVID-19: to be or not to be; that is the diagnostic question. Postgrad Med J 2020; 96: 392–398.

35.

Hebert

Ridgway

Vekhter

, et al. Demonstration of the weighted-incidence syndromic combination antibiogram: an empiric prescribing decision aid. Infect Control Hosp Epidemiol 2012; 33: 381–388.

36.

Pinder

Sallis

Berry

, et al. Antibiotic prescribing and behavior change in healthcare settings: literature review and behavioural analysis. London, UK: Department of Health & Public Health England, 2015.

37.

Zeng

Shi

Liu

, et al. Effects of social norm feedback on antibiotic prescribing and its characteristics in behavior change techniques: a mixed-methods systematic review. Lancet Infect Dis 2022; 23: E175–E184.

38.

Zetts

Stoesz

Garcia

, et al. Primary care physicians’ attitudes and perceptions towards antibiotic resistance and outpatient antibiotic stewardship in the USA: a qualitative study. BMJ Open 2020; 10: E034983.

39.

Saleh

Borg

Stålsby Lundborg

, et al. General Practitioners’, Pharmacists’ and Parents’ Views on Antibiotic Use and Resistance in Malta: An Exploratory Qualitative Study. Antibiotics (Basel) 2022; 11: 661.

40.

Norman

Svensson

Schmidt

, et al. Reduced dispensing of prescribed antibiotics during the Covid-19 pandemic has not increased severe complications from common infections. BMC Public Health 2022; 22: 252.

41.

Shehab

Patel

Srinivasan

, et al. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis 2008; 47: 735–743.

42.

Petersen

Johnson

Islam

, et al. Protective effect of antibiotics against serious complications of common respiratory tract infections: retrospective cohort study with the UK General Practice Research Database. BMJ 2007; 335: 982.

43.

Romano

Galante

Figueira

, et al. Time-trend analysis of medicine sales and shortages during COVID-19 outbreak: Data from community pharmacies. Res Social Adm Pharm 2021; 17: 1876–1881.

44.

Miljković

Polidori

Kohl

Managing antibiotic shortages: lessons from EAHP and ECDC surveys. Eur J Hosp Pharm 2022; 29: 90–94.

45.

Sheu

Fung

Mourad

, et al. We need to talk: Primary care provider communication at discharge in the era of a shared electronic medical record. J Hosp Med 2015; 10: 307–310.

46.

Robelia

Kashiwagi

Jenkins

, et al. Information Transfer and the Hospital Discharge Summary: National Primary Care Provider Perspectives of Challenges and Opportunities. J Am Board Fam Med 2017; 30: 758–765.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.16 MB

0.12 MB